This study focuses on patients in Intensive Care Unit (ICU) who are at risk of developing Acute Respiratory Distress Syndrome (ARDS), a serious lung condition that makes it difficult to breathe. The main treatment being studied is sevoflurane, a medication that is inhaled as a vapor, compared to standard medications given through a vein for keeping patients calm and comfortable while on a breathing machine.
The purpose of the study is to determine if inhaled sevoflurane can improve oxygen levels in the blood better than traditional medications. The other medications that may be used in the study include dexmedetomidine, cisatracurium, midazolam, and propofol, which are all given through a vein. These medications are commonly used to help keep patients comfortable while they are receiving support from a breathing machine.
During the study, patients will receive either sevoflurane through a breathing system or the standard medications through their veins for up to 5 days. The doctors will monitor how well patients’ lungs work by measuring oxygen levels and checking for signs of lung problems. They will also track other important health information such as infections, time spent on breathing machines, and length of stay in the intensive care unit.



France